Company on track to submit Investigational New Drug application for CPI-818 in early 2019 BURLINGAME, Calif., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback